Prostate Cancer
Reviews

Volume 7 Number 1
January 2019

Home > Disciplines > Publications > Prostate Cancer Reviews > Volume 7, Year 2019 > Number 1, January

CONTENTS

▼

DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
FOLLOW-UP, QUALITY OF LIFE
TREATMENT

DIAGNOSIS

▲

.

Cackowski FC, Taichman RS.
Minimal Residual Disease in Prostate Cancer.
Adv Exp Med Biol. 2018;1100:47-53. doi: 10.1007/978-3-319-97746-1_3. Epub 2018 Nov 9.
Source . Similar articles

.

Cantiello F, Russo GI, Kaufmann S, Cacciamani G, Crocerossa F, Ferro M, De Cobelli O, Artibani W, Cimino S, Morgia G, Damiano R, Nikolaou K, Kröger N, Stenzl A, Bedke J, Kruck S.
Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis.
Prostate Cancer Prostatic Dis. 2018 Nov 28. doi: 10.1038/s41391-018-0113-2. [Epub ahead of print]
Source . Similar articles

.

Chatterjee A, Oto A.
Future Perspectives in Multiparametric Prostate MR Imaging.
Magn Reson Imaging Clin N Am. 2019 Feb;27(1):117-130. doi: 10.1016/j.mric.2018.08.003. Epub 2018 Nov 20.
Source . Similar articles

.

Carlsson SV, Lilja H.
Perspective on Prostate Cancer Screening.
Clin Chem. 2019 Jan;65(1):24-27. doi: 10.1373/clinchem.2018.293514. Epub 2018 Nov 20.
Source . Similar articles

.

Glaser ZA, Rais-Bahrami S.
Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer.
Transl Androl Urol. 2018 Oct;7(5):824-830. doi: 10.21037/tau.2018.07.17.
Source . Similar articles

.

Malik D, Sood A, Mittal BR, Singh H, Basher RK, Shukla J, Bhattacharya A, Singh SK.
Nonspecific Uptake of ⁶⁸Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature.
Indian J Nucl Med. 2018 Oct-Dec;33(4):317-325. doi: 10.4103/ijnm.IJNM_81_18.
Source . Similar articles

.

Mehralivand S, van der Poel H, Winter A, Choyke PL, Pinto PA, Turkbey B.
Sentinel lymph node imaging in urologic oncology.
Transl Androl Urol. 2018 Oct;7(5):887-902. doi: 10.21037/tau.2018.08.23.
Source . Similar articles

.

Rayn KN, Elnabawi YA, Sheth N.
Clinical implications of PET/CT in prostate cancer management.
Transl Androl Urol. 2018 Oct;7(5):844-854. doi: 10.21037/tau.2018.08.26.
Source . Similar articles

.

Tangel MR, Rastinehad AR.
Advances in prostate cancer imaging.
F1000Res. 2018 Aug 24;7. pii: F1000 Faculty Rev-1337. doi: 10.12688/f1000research.14498.1. eCollection 2018.
Source . Similar articles

EPIDEMIOLOGY, RISK FACTORS, PREVENTION

▲

.

Dickerman B, Mucci L.
Metabolic Factors and Prostate Cancer Risk.
Clin Chem. 2019 Jan;65(1):42-44. doi: 10.1373/clinchem.2018.287243. Epub 2018 Nov 20.
Source . Similar articles

.

Sauer CM, Myran DT, Costentin CE, Zwisler G, Safder T, Papatheodorou S, Mucci LA.
Effect of long term aspirin use on the incidence of prostate cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2018 Dec;132:66-75. doi: 10.1016/j.critrevonc.2018.09.013. Epub 2018 Sep 29.
Source . Similar articles

FOLLOW-UP, QUALITY OF LIFE

▲

.

Fiorentino A, Errico A, Scarcia M.
Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28.
Eur Urol. 2019 Apr;75(4):e93-e94. doi: 10.1016/j.eururo.2018.11.024. Epub 2018 Nov 27.
Source . Similar articles
Comment on: Moschini M et al, External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol. 2019 Feb;75(2):319-328. doi: 10.1016/j.eururo.2018.09.034. Epub 2018 Oct 4. Source . Similar articles

.

Garcia-Baquero R, Fernandez-Avila CM, Alvarez-Ossorio JL.
Functional results in the treatment of localized prostate cancer. An updated literature review.
Rev Int Androl. 2018 Nov 23. pii: S1698-031X(18)30085-2. doi: 10.1016/j.androl.2018.06.002. [Epub ahead of print]
Source . Similar articles

.

Moschini M, Zaffuto E, Mattei A, Karakiewicz PI, Shariat SF.
Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28.
Eur Urol. 2019 Apr;75(4):e95. doi: 10.1016/j.eururo.2018.11.043. Epub 2018 Nov 30.
Source . Similar articles
Comment on: Fiorentino A, et al., Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28.
Eur Urol. 2019 Apr;75(4):e93-e94. doi: 10.1016/j.eururo.2018.11.024. Epub 2018 Nov 27. Source . Similar articles

.

Moschini M, Zaffuto E, Mattei A, Karakiewicz PI, Shariat SF.
Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28.
Eur Urol. 2019 Apr;75(4):e98-e99. doi: 10.1016/j.eururo.2018.11.042. Epub 2018 Nov 30.
Source . Similar articles
Comment on. Zaorsky NG, et al., Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28. Eur Urol. 2019 Apr;75(4):e96-e97. doi: 10.1016/j.eururo.2018.11.025. Epub 2018 Nov 22. Source . Similar articles

.

Walsh PC.
RE: Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.
J Natl Cancer Inst. 2018 Oct 30. doi: 10.1093/jnci/djy186. [Epub ahead of print]
Source . Similar articles
Comment on: Wallerstedt A et al, Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study. J Natl Cancer Inst. 2018 Nov 1;110(11):1216-1221. doi: 10.1093/jnci/djy036. Epub 2018 Mar 14. Source . Similar articles

.

Zaorsky NG, Spratt DE, Blanchard P.
Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28.
Eur Urol. 2019 Apr;75(4):e96-e97. doi: 10.1016/j.eururo.2018.11.025. Epub 2018 Nov 22.
Source . Similar articles
Comment on: Moschini M et al, External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol. 2019 Feb;75(2):319-328. doi: 10.1016/j.eururo.2018.09.034. Epub 2018 Oct 4. Source . Similar articles

TREATMENT

▲

.

Anker MS, Lehmann LH, Anker SD.
Enzalutamide in Castration-Resistant Prostate Cancer.
N Engl J Med. October 4, 2018; 379:1380-1381. DOI: 10.1056/NEJMc1810065
Source . Similar articles
Comment on: Hussain M, et al., Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. N Engl J Med. 2018 Jun 28;378(26):2465-2474. doi: 10.1056/NEJMoa1800536. Source . Similar articles

.

Beaver JA, Kluetz PG, Pazdur R.
Metastasis-free Survival - A New End Point in Prostate Cancer Trials.
N Engl J Med. 2018 Jun 28;378(26):2458-2460. doi: 10.1056/NEJMp1805966.
Source . Similar articles
Comment on: Hussain M, et al., Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. N Engl J Med. 2018 Jun 28;378(26):2465-2474. doi: 10.1056/NEJMoa1800536. Source . Similar articles

.

Body A, Pranavan G, Tan TH, Slobodian P.
Medical management of metastatic prostate cancer.
Aust Prescr. 2018 Oct;41(5):154-159. doi: 10.18773/austprescr.2018.046. Epub 2018 Oct 2.
Source . Similar articles

.

Chow K, McCoy P, Stuchbery R, Corcoran NM, Hovens CM.
Developments in oligometastatic hormone-sensitive prostate cancer.
World J Urol. 2018 Oct 31. doi: 10.1007/s00345-018-2542-x. [Epub ahead of print]
Source . Similar articles

.

García-Perdomo HA, Correa-Ochoa JJ, Contreras-García R, Daneshmand S.
Effectiveness of extended pelvic lymphadenectomy in the survival of prostate cancer: a systematic review and meta-analysis.
Cent European J Urol. 2018;71(3):262-269. doi: 10.5173/ceju.2018.1703. Epub 2018 Aug 20.
Source . Similar articles

.

Ingrosso G, Detti B, Scartoni D, Lancia A, Giacomelli I, Baki M, Carta G, Livi L, Santoni R.
Current therapeutic options in metastatic castration-resistant prostate cancer.
Semin Oncol. 2018 Oct 30. pii: S0093-7754(17)30050-7. doi: 10.1053/j.seminoncol.2018.10.001. [Epub ahead of print]
Source . Similar articles

.

Kessler ER.
Management of Metastatic Prostate Cancer in Frail/Elderly Patients.
Oncology (Williston Park). 2018 Nov 15;32(11):570-3.
Source . Similar articles .

.

Kretschmer A, Todenhöfer T.
Are There Still Patients with Metastatic Hormone-sensitive Prostate Cancer Who Should Be Treated with Androgen Deprivation Monotherapy?
Eur Urol Focus. 2018 Nov 24. pii: S2405-4569(18)30360-2. doi: 10.1016/j.euf.2018.11.008. [Epub ahead of print]
Source . Similar articles

.

Linder S, van der Poel HG, Bergman AM, Zwart W, Prekovic S.
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
Endocr Relat Cancer. 2018 Oct 31;26(1):R31-R52. doi: 10.1530/ERC-18-0289.
Source . Similar articles

.

Mathew MS, Oto A.
MR Imaging-Guided Focal Therapies of Prostate Cancer.
Magn Reson Imaging Clin N Am. 2019 Feb;27(1):131-138. doi: 10.1016/j.mric.2018.08.004. Epub 2018 Oct 29.
Source . Similar articles

.

McClintock TR, von Landenberg N, Cole AP, Lipsitz SR, Gild P, Sun M, Fletcher SA, Roghmann F, Menon M, Nguyen PL, Noldus J, Choueiri TK, Kibel AS, Trinh QD.
Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin Status.
Ann Surg Oncol. 2018 Nov 14. doi: 10.1245/s10434-018-7035-z. [Epub ahead of print]
Source . Similar articles

.

Ploussard G, Gandaglia G, Borgmann H, de Visschere P, Heidegger I, Kretschmer A, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, Ost P, Briganti A; EAU-YAU Prostate Cancer Working Group.
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
Eur Urol. 2018 Oct 31. pii: S0302-2838(18)30836-4. doi: 10.1016/j.eururo.2018.10.041. [Epub ahead of print]
Source . Similar articles

.

Printz C.
New drug option for men with aggressive prostate cancer.
Cancer. 2018 Oct 1;124(19):3797. doi: 10.1002/cncr.31753. First published: 09 November 2018.
Source . Similar articles

.

Reis LO.
Metastasis-free Survival-Progress or Lowering the Bar on Nonmetastatic Prostate Cancer?
Eur Urol. 2018 Nov;74(5):682-683. doi: 10.1016/j.eururo.2018.08.018. Epub 2018 Aug 28.
Source . Similar articles

.

Rescigno P, de Bono JS.
Immunotherapy for lethal prostate cancer.
Nat Rev Urol. 2018 Nov 22. doi: 10.1038/s41585-018-0121-y. [Epub ahead of print]
Source . Similar articles

.

Rhea LP, Gupta B, Aragon-Ching JB.
Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer.
Asian J Androl. 2018 Nov 20. doi: 10.4103/aja.aja_88_18. [Epub ahead of print]
Source . Similar articles
Comment on: Hussain M, et al., Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. N Engl J Med. 2018 Jun 28;378(26):2465-2474. doi: 10.1056/NEJMoa1800536. Source . Similar articles

.

Roobol MJ.
Active Surveillance for Low-risk Prostate Cancer: Will it Become Obsolete?
Eur Urol. 2018 Oct 25. pii: S0302-2838(18)30809-1. doi: 10.1016/j.eururo.2018.10.021. [Epub ahead of print]
Source . Similar articles
Comment on: Carter HB et al, Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer. Eur Urol. 2018 Oct 8. pii: S0302-2838(18)30684-5. doi: 10.1016/j.eururo.2018.09.021. [Epub ahead of print]. Source . Similar articles

.

Sartor O.
Advanced prostate cancer update 2018.
Asia Pac J Clin Oncol. 2018 Nov;14 Suppl 5:9-12. doi: 10.1111/ajco.13057.
Source . Similar articles

.

Smith MR.
Progress in Nonmetastatic Prostate Cancer.
N Engl J Med. 2018 Jun 28;378(26):2531-2532. doi: 10.1056/NEJMe1805733.
Source . Similar articles
Comment on: Carter HB et al, Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer. Eur Urol. 2018 Oct 8. pii: S0302-2838(18)30684-5. doi: 10.1016/j.eururo.2018.09.021. [Epub ahead of print]. Source . Similar articles

.

Tucci M, Zichi C, Buttigliero C, Vignani F, Scagliotti GV, Di Maio M.
Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions.
Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.
Source . Similar articles

.

Yuan Y, Kishan AU, Nickols NG.
Treatment of the primary tumor in metastatic prostate cancer.
World J Urol. 2018 Nov 19. doi: 10.1007/s00345-018-2552-8. [Epub ahead of print]
Source . Similar articles

bottom

▲